Drossou V - Search Results

1

Colchicine Against SARS-CoV-2 Infection: What is the Evidence?

Drosos AA, Pelechas E, Drossou V, Voulgari PV. Drosos AA, et al. Among authors: drossou v. Rheumatol Ther. 2022 Apr;9(2):379-389. doi: 10.1007/s40744-022-00425-0. Epub 2022 Feb 2. Rheumatol Ther. 2022. PMID: 35107804 Free PMC article. Review.

2

Anti-Rheumatic Drugs for the Fight Against the Novel Coronavirus Infection (SARSCoV-2): What is the Evidence?

Pelechas E, Drossou V, Voulgari PV, Drosos AA. Pelechas E, et al. Among authors: drossou v. Mediterr J Rheumatol. 2020 Sep 21;31(Suppl 2):259-267. doi: 10.31138/mjr.31.3.259. eCollection 2020 Sep. Mediterr J Rheumatol. 2020. PMID: 33196003 Free PMC article. Review.

3

Use of conventional synthetic and biologic disease-modifying anti-rheumatic drugs in patients with rheumatic diseases contracting COVID-19: a single-center experience.

Migkos MP, Kaltsonoudis E, Pelechas E, Drossou V, Karagianni PG, Kavvadias A, Voulgari PV, Drosos AA. Migkos MP, et al. Among authors: drossou v. Rheumatol Int. 2021 May;41(5):903-909. doi: 10.1007/s00296-021-04818-2. Epub 2021 Mar 3. Rheumatol Int. 2021. PMID: 33655421 Free PMC article.

4

COVID-19 in patients with gout on colchicine.

Pelechas E, Drossou V, Voulgari PV, Drosos AA. Pelechas E, et al. Among authors: drossou v. Rheumatol Int. 2021 Aug;41(8):1503-1507. doi: 10.1007/s00296-021-04902-7. Epub 2021 Jun 5. Rheumatol Int. 2021. PMID: 34089357 Free PMC article. Review.

5

A Response to: Letter to the Editor Regarding the Article: "Colchicine Against SARS-CoV-2 Infection: What is the Evidence?".

Drosos AA, Pelechas E, Drossou V, Voulgari PV. Drosos AA, et al. Among authors: drossou v. Rheumatol Ther. 2022 Aug;9(4):1233-1235. doi: 10.1007/s40744-022-00457-6. Epub 2022 May 27. Rheumatol Ther. 2022. PMID: 35622237 Free PMC article. No abstract available.

6

Anti-Rheumatic Drugs May Ameliorate the Clinical Course and Outcome of COVID-19 In Rheumatoid Arthritis Patients.

Pelechas E, Drossou V, Voulgari PV, Drosos AA. Pelechas E, et al. Among authors: drossou v. Mediterr J Rheumatol. 2022 Mar 31;33(1):68-74. doi: 10.31138/mjr.33.1.68. eCollection 2022 Mar. Mediterr J Rheumatol. 2022. PMID: 35611100 Free PMC article.

7

Impact of European legislation on marketed pesticides--a view from the standpoint of health impact assessment studies.

Karabelas AJ, Plakas KV, Solomou ES, Drossou V, Sarigiannis DA. Karabelas AJ, et al. Among authors: drossou v. Environ Int. 2009 Oct;35(7):1096-107. doi: 10.1016/j.envint.2009.06.011. Epub 2009 Jul 25. Environ Int. 2009. PMID: 19632722 Review.

8

Early abnormal amplitude-integrated electroencephalography (aEEG) is associated with adverse short-term outcome in premature infants.

Soubasi V, Mitsakis K, Sarafidis K, Griva M, Nakas CT, Drossou V. Soubasi V, et al. Among authors: drossou v. Eur J Paediatr Neurol. 2012 Nov;16(6):625-30. doi: 10.1016/j.ejpn.2012.02.008. Epub 2012 Mar 15. Eur J Paediatr Neurol. 2012. PMID: 22425390

9

The influence of extrauterine life on the aEEG maturation in normal preterm infants.

Soubasi V, Mitsakis K, Nakas CT, Petridou S, Sarafidis K, Griva M, Agakidou E, Drossou V. Soubasi V, et al. Among authors: drossou v. Early Hum Dev. 2009 Dec;85(12):761-5. doi: 10.1016/j.earlhumdev.2009.10.004. Epub 2009 Nov 17. Early Hum Dev. 2009. PMID: 19919892

10

Urine metabolomic profile in neonates with hypoxic-ischemic encephalopa-thy.

Sarafidis K, Efstathiou N, Begou O, Soubasi V, Agakidou E, Gika E, Theodoridis G, Drossou V. Sarafidis K, et al. Among authors: drossou v. Hippokratia. 2017 Apr-Jun;21(2):80-84. Hippokratia. 2017. PMID: 30455560 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page